Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MITSUDOMI, Tetsuya")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 115

  • Page / 5
Export

Selection :

  • and

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerMITSUDOMI, Tetsuya; YATABE, Yasushi.Cancer science. 2007, Vol 98, Num 12, pp 1817-1824, issn 1347-9032, 8 p.Article

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destinySUDA, Kenichi; MIZUUCHI, Hiroshi; MAEHARA, Yoshihiko et al.Cancer metastasis reviews. 2012, Vol 31, Num 3-4, pp 807-814, issn 0167-7659, 8 p.Article

Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung AdenocarcinomaYATABE, Yasushi; MATSUO, Keitaro; MITSUDOMI, Tetsuya et al.Journal of clinical oncology. 2011, Vol 29, Num 22, pp 2972-2977, issn 0732-183X, 6 p.Article

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation : Lung cancerSUDA, Kenichi; TOMIZAWA, Kenji; MITSUDOMI, Tetsuya et al.Cancer metastasis reviews. 2010, Vol 29, Num 1, pp 49-60, issn 0167-7659, 12 p.Article

TTF-1 expression in pulmonary adenocarcinomasYATABE, Yasushi; MITSUDOMI, Tetsuya; TAKAHASHI, Takashi et al.The American journal of surgical pathology. 2002, Vol 26, Num 6, pp 767-773, issn 0147-5185Article

Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung CancerYATABE, Yasushi; TAKAHASHI, Takashi; MITSUDOMI, Tetsuya et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2106-2111, issn 0008-5472, 6 p.Article

EGFR mutation is specific for terminal respiratory unit type adenocarcinomaYATABE, Yasushi; KOSAKCI, Takayuki; TAKAHASHI, Takashi et al.The American journal of surgical pathology. 2005, Vol 29, Num 5, pp 633-639, issn 0147-5185, 7 p.Article

Impact of EGFR mutation analysis in non-small cell lung cancerYAMAMOTO, Hiromasa; TOYOOKA, Shinichi; MITSUDOMI, Tetsuya et al.Lung cancer. 2009, Vol 63, Num 3, pp 315-321, issn 0169-5002, 7 p.Article

CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomasYATABE, Yasushi; KOGA, Takaomi; MITSUDOMI, Tetsuya et al.Journal of pathology. 2004, Vol 203, Num 2, pp 645-652, issn 0022-3417, 8 p.Article

Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylationYATABE, Yasushi; MITSUDOMI, Tetsuya; TAKAHASHI, Takashi et al.Oncogene (Basingstoke). 2004, Vol 23, Num 23, pp 4041-4049, issn 0950-9232, 9 p.Article

Predictors of Survival in Patients With Bone Metastasis of Lung CancerSUGIURA, Hideshi; YAMADA, Kenji; SUGIURA, Takahiko et al.Clinical orthopaedics and related research. 2008, Vol 466, Num 3, pp 729-736, issn 0009-921X, 8 p.Article

Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potentialYATABE, Yasushi; OSADA, Hirotaka; TATEMATSU, Yoshio et al.Oncogene (Basingstoke). 2002, Vol 21, Num 54, pp 8310-8319, issn 0950-9232, 10 p.Article

Topographical distributions of allelic loss in individual non-small-cell lung cancersYATABE, Yasushi; KONISHI, Hiroyuki; MITSUDOMI, Tetsuya et al.The American journal of pathology. 2000, Vol 157, Num 3, pp 985-993, issn 0002-9440Article

Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung CancerKITAMURA, Atsuko; HOSODA, Waki; SASAKI, Eiichi et al.Clinical cancer research (Print). 2010, Vol 16, Num 13, pp 3349-3355, issn 1078-0432, 7 p.Article

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancersFUKUI, Takayuki; MORI, Shoichi; HATOOKA, Shunzo et al.Journal of thoracic and cardiovascular surgery (Print). 2008, Vol 136, Num 5, pp 1343-1348, issn 0022-5223, 6 p.Article

Validation of a Nomogram for Predicting Overall Survival After Resection of Pulmonary Metastases from Colorectal Cancer at a Single CenterKANEMITSU, Yukihide; KATO, Tomoyuki; KOMORI, Koji et al.World journal of surgery. 2010, Vol 34, Num 12, pp 2973-2978, issn 0364-2313, 6 p.Article

Throwing new light on lung cancer pathogenesis : Updates on three recent topicsTOMIDA, Shuta; YATABE, Yasushi; YANAGISAWA, Kiyoshi et al.Cancer science. 2005, Vol 96, Num 2, pp 63-68, issn 1347-9032, 6 p.Article

The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptorSUDA, Kenichi; MIZUUCHI, Hiroshi; SATO, Katsuaki et al.International journal of cancer (Print). 2014, Vol 135, Num 4, pp 1002-1006, issn 0020-7136, 5 p.Article

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancerYANAGISAWA, Kiyoshi; TOMIDA, Shuta; SHIMADA, Yukako et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 11, pp 858-867, issn 0027-8874, 10 p.Article

The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case ExampleLI-WAN-PO, Alain; FARNDON, Peter A; KOBAYASHI, Susumu et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 2, pp 263-275, issn 1060-0280, 13 p.Article

Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasisFUKUI, Takayuki; KATAYAMA, Tatsuya; ITO, Simon et al.Lung cancer. 2009, Vol 66, Num 3, pp 309-313, issn 0169-5002, 5 p.Article

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in JapanICHINOSE, Yukito.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s43-s48, SUP1Conference Paper

Defining clinically relevant molecular subsets of lung cancerPAO, William.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s11-s15, SUP1Conference Paper

Clinical development of EGFR-tyrosine kinase inhibitors in JapanNAKAGAWA, Kazuhiko.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s33-s37, SUP1Conference Paper

RASSFIA gene inactivation in non-small cell lung cancer and its clinical implicationENDOH, Hideki; YATABE, Yasushi; SHIMIZU, Shigeki et al.International journal of cancer. 2003, Vol 106, Num 1, pp 45-51, issn 0020-7136, 7 p.Article

  • Page / 5